Patents by Inventor Josh ELDRIDGE

Josh ELDRIDGE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NON-CRYSTALLIZING CANNABIDIOL BLENDS
    Publication number: 20230226001
    Abstract: A non-crystallizing blend includes cannabidiol (CBD) and cannabidiolic acid (CBDA). A method of forming a non-crystallizing blend of CBD and CBDA includes obtaining a CBD isolate including at least 80% by weight CBD, obtaining a CBDA isolate including at least 80% by weight CBDA, and combining and mixing the CBD isolate and the CBDA. A method of treating a condition includes administering a therapeutically effective amount of a non-crystallizing blend of CBD and CBDA to a patient in need thereof.
    Type: Application
    Filed: March 24, 2023
    Publication date: July 20, 2023
    Inventors: Andrew HORVATH, Scott DAVIS, Matthew MOORE, Josh ELDRIDGE, James HOOK, William LANIER
  • Non-crystallizing cannabidiol blends
    Patent number: 11648219
    Abstract: A non-crystallizing blend includes cannabidiol (CBD) and cannabidiolic acid (CBDA). A method of forming a non-crystallizing blend of CBD and CBDA includes obtaining a CBD isolate including at least 80% by weight CBD, obtaining a CBDA isolate including at least 80% by weight CBDA, and combining and mixing the CBD isolate and the CBDA. A method of treating a condition includes administering a therapeutically effective amount of a non-crystallizing blend of CBD and CBDA to a patient in need thereof.
    Type: Grant
    Filed: January 26, 2021
    Date of Patent: May 16, 2023
    Assignee: CHEMTOR, LP
    Inventors: Andrew Horvath, Scott Davis, Matthew Moore, Josh Eldridge, James Hook, William Lanier
  • NON-CRYSTALLIZING CANNABIDIOL BLENDS
    Publication number: 20210228513
    Abstract: A non-crystallizing blend includes cannabidiol (CBD) and cannabidiolic acid (CBDA). A method of forming a non-crystallizing blend of CBD and CBDA includes obtaining a CBD isolate including at least 80% by weight CBD, obtaining a CBDA isolate including at least 80% by weight CBDA, and combining and mixing the CBD isolate and the CBDA. A method of treating a condition includes administering a therapeutically effective amount of a non-crystallizing blend of CBD and CBDA to a patient in need thereof.
    Type: Application
    Filed: January 26, 2021
    Publication date: July 29, 2021
    Inventors: Andrew HORVATH, Scott DAVIS, Matthew MOORE, Josh ELDRIDGE, James HOOK, William LANIER
  • Abuse deterrent opioid/opioid-antagonist transdermal patch
    Patent number: 10238648
    Abstract: An abuse deterrent transdermal patch comprising a multilaminate. The multilaminate can comprise a first layer comprising an opioid analgesic compound, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable pressure sensitive adhesive. The multilaminate can further comprise a second layer comprising an opioid antagonist, or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable adhesive. In addition, the multilaminate can further comprise a barrier layer disposed between the first and second layers.
    Type: Grant
    Filed: July 17, 2015
    Date of Patent: March 26, 2019
    Assignee: BUZZZ PHARMACEUTICALS LTD.
    Inventors: Audra Lynn Stinchcomb, Dana Carmel Hammell, Stan Lee Banks, Josh Eldridge, Miroslaw Jerzy Golinski
  • Oxymorphone transdermal patch
    Patent number: 10071090
    Abstract: The present invention relates to a transdermal patch comprising oxymorphone. The present invention also relates to processes for the preparation of the transdermal patches defined herein, as well as to the use of these patches for the treatment of pain.
    Type: Grant
    Filed: July 17, 2015
    Date of Patent: September 11, 2018
    Assignee: BUZZZ PHARMACEUTICALS LIMITED
    Inventors: Audra Lynn Stinchcomb, Dana Carmel Hammell, Stan Lee Banks, Josh Eldridge, Miroslaw Jerzy Golinski
  • ABUSE DETERRENT OPIOD/OPIOD-ANTAGONIST TRANSDERMAL PATCH
    Publication number: 20170209429
    Abstract: The present invention relates to an abuse deterrent transdermal patch.
    Type: Application
    Filed: July 17, 2015
    Publication date: July 27, 2017
    Inventors: Audra Lynn STINCHCOMB, Dana Carmel HAMMELL, Stan Lee BANKS, Josh ELDRIDGE, Miroslaw Jerzy GOLINSKI
  • OXYMORPHONE TRANSDERMAL PATCH
    Publication number: 20170202830
    Abstract: The present invention relates to a transdermal patch comprising oxymorphone. The present invention also relates to processes for the preparation of the transdermal patches defined herein, as well as to the use of these patches for the treatment of pain.
    Type: Application
    Filed: July 17, 2015
    Publication date: July 20, 2017
    Inventors: Audra Lynn STINCHCOMB, Dana Carmel HAMMELL, Stan Lee BANKS, Josh ELDRIDGE, Miroslaw Jerzy GOLINSKI